Navigation Links
Mayer Labs Acquires Today(R) Sponge Distribution Rights

BERKELEY, Calif., April 6 /PRNewswire/ -- Mayer Laboratories, Inc., a marketer and distributor of high-quality contraceptive and other reproductive healthcare products, announced today that it has signed an agreement with Alvogen Group for the exclusive distribution rights of the Today Sponge for the United States, Europe and Canada.

For more than 20 years, Mayer Labs has marketed and distributed contraceptive and reproductive healthcare products in the United States and abroad. According to David Mayer, CEO of Mayer Labs, "we are very excited to add the Today Sponge to our portfolio of high quality reproductive products. Today Sponge has always remained popular with many consumer advantages; the recent interruption of distribution was not the result of product quality or market viability, but was due to the previous owner's overleveraged financial condition, which ultimately lead to their bankruptcy."

According to Doug Drysdale, CEO of Alvogen, "We considered several distribution partners for the Today Sponge. We selected Mayer Labs based on their expertise in this segment and their reputation as a valued and committed partner."

Originally introduced in 1983 and later acquired by Wyeth, the Today Sponge affords the freedom and flexibility of 24-hour contraceptive protection, and offers a safe and effective non-hormonal birth control alternative for millions of American women. The Today Sponge is a popular over-the-counter birth control method for women, with over 150 million sponges sold since its introduction.

About Mayer Laboratories, Inc.

Mayer Labs is an innovative, California-based company with 20 years experience in marketing and distributing the best quality contraceptive and reproductive healthcare products in the United States and abroad. Mayer Labs' products include Kimono brand condoms, FC Female Condom, and Aqua Lube personal lubricants. For more information visit:

About Alvogen Group

Alvogen is a specialty pharmaceutical company focused on developing, producing and marketing complex, high value specialty and generic drugs; providing access to such medications; and improving the quality of life for millions of Americans. Alvogen owns Norwich Pharmaceuticals, Inc. based in Norwich, NY. Norwich is the FDA approved contract manufacturer of the Today Sponge. With a rich heritage and access to an extensive portfolio, pipeline and resources, Alvogen has successfully attracted additional investment from its leading equity partner - New York City based AFI partners. Funds are applied to expanding Alvogen's product portfolio and pipeline, as well as expanding manufacturing capabilities at its Norwich, NY facilities.

Today(R) is a registered trademark of Alvogen Group

    David Mayer, CEO
    510.229.5300 ext. 5305

SOURCE Mayer Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
2. International Isotopes Inc. Names James Mayer as Chief Operating Officer
3. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
4. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
5. Food Bank For New York City Acquires FoodChange
6. Concentra Acquires Assets of Renew Health & Wellness
7. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
8. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
9. NNN Healthcare/Office REIT Acquires 2750 Monroe Boulevard in Valley Forge, Pennsylvania
10. Hologic Acquires Biolucent, Inc.
11. Radiation Therapy Services Acquires North Carolina Facility
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... of non-traumatic limb amputations in the United States. Podiatrists are well aware that ... to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Center of Excellence (BHCOE) today announced that the organization has awarded Education and ... Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers that ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
(Date:12/1/2015)... Beverly Hills, CA (PRWEB) , ... December 01, ... ... honored by Modern Luxury’s Angeleno Magazine as a Modern Man for 2015. ... luxury lifestyle publisher in the United States. Established in 1994, Modern Luxury includes ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 2015 ... of the "2016 Europe Enteric ... Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, ... offering. --> ) ... "2016 Europe Enteric Disease Testing ...
Breaking Medicine Technology: